LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $466,000 | +23200.0% | 4,683 | +29168.8% | 0.00% | – |
| Q2 2020 | $2,000 | -99.3% | 16 | -99.6% | 0.00% | -100.0% |
| Q1 2020 | $302,000 | -5.6% | 4,152 | +35.4% | 0.00% | 0.0% |
| Q4 2019 | $320,000 | -93.1% | 3,067 | -91.7% | 0.00% | -88.9% |
| Q1 2019 | $4,651,000 | -61.1% | 37,000 | -58.0% | 0.01% | -66.7% |
| Q4 2018 | $11,968,000 | +19.1% | 88,200 | +141.0% | 0.03% | +42.1% |
| Q3 2018 | $10,046,000 | +331.7% | 36,600 | +60.5% | 0.02% | +111.1% |
| Q3 2016 | $2,327,000 | -46.3% | 22,800 | -37.2% | 0.01% | -50.0% |
| Q2 2016 | $4,330,000 | -5.7% | 36,300 | -15.4% | 0.02% | -5.3% |
| Q1 2016 | $4,594,000 | +8.4% | 42,900 | +9.7% | 0.02% | -5.0% |
| Q4 2015 | $4,239,000 | +73.7% | 39,100 | +37.2% | 0.02% | +100.0% |
| Q3 2015 | $2,441,000 | +12105.0% | 28,500 | +9400.0% | 0.01% | – |
| Q1 2014 | $20,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |